Helsinn, DARA sign licensing agreement for Gelclair
DARA plans to launch Gelclair, a topical gel used to coat and protect the oral cavity to reduce pain, in the first quarter of 2013. DARA chief executive
Vertex has signed a definitive agreement to purchase Crinetics Pharmaceuticals in a transaction valued at nearly $10bn, or $8.8bn net of estimated cash acquired.
Reverse-vine is an extract which contains stilbenes, natural compounds produced by the grapevine as part of their defense system including resveratrol, reports naturalproductsinside. In addition, the product includes
The company anticipates initiation of product shipment shortly. Lannett president and chief executive officer Arthur Bedrosian said that sales of Butalbital, Acetaminophen and Caffeine tablets have been climbing